Cargando…

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate

BACKGROUND: A minority of infantile hemangiomas showing minimal or arrested growth (IH-MAGs) have been recognized in the literature. Nevertheless, the clinical features and treatment outcomes of IH-MAGs have not been well investigated. OBJECTIVE: This study aimed to understand the clinical character...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Kyung-Nam, Shin, Kihyuk, Kim, Hoon-Soo, Kim, Byung-Soo, Kim, Moon-Bum, Ko, Hyun-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460486/ https://www.ncbi.nlm.nih.gov/pubmed/34616126 http://dx.doi.org/10.5021/ad.2021.33.5.448

Ejemplares similares

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2016)

Timing and Efficacy of 595-nm Pulsed-Dye Laser Combined with 0.5% Timolol Maleate Solution in the Treatment of Superficial Infantile Hemangiomas
por: Shi, Weikang, et al.
Publicado: (2021)

Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas
por: Tong, Shuang, et al.
Publicado: (2016)

Complicated Infantile Hemangioma Successfully Treated with Topical Timolol 0.5% Solution: A Case Report
por: Borkar, Nitin, et al.
Publicado: (2021)

Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma
por: Wu, Jianming, et al.
Publicado: (2021)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Dermoscopic Evaluation of Infantile Hemangioma Treated With Topical Timolol
por: Jassi, Rubina, et al.
Publicado: (2020)

Deeply Located Infantile Hemangioma with Rapid Growth Resembles Malignancy
por: Ha, Dae-Lyong, et al.
Publicado: (2021)

Efficacious Healing of Ulcerated Infantile Hemangiomas Using Topical Timolol
por: Chang, Chun-Shin, et al.
Publicado: (2016)

A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
por: Stewart, William C, et al.
Publicado: (2013)

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
por: Wu, Hai Wei, et al.
Publicado: (2018)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
por: Roy, Kakoli, et al.
Publicado: (2012)

Sick sinus syndrome associated with topical timolol maleate instillation
por: Walia, Harpreet S., et al.
Publicado: (2011)

Topical Timolol: A Safer Alternative for Complicated and Un-Complicated Infantile Hemangiomas
por: Ambika, Hariharasubramony, et al.
Publicado: (2013)

Comment on “Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate”
por: Arunachalam, Cynthia
Publicado: (2013)

Hyperkalemia due to topical timolol for hemangioma
por: Alasmari, Bushra, et al.
Publicado: (2023)

Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study
por: Ge, Jing, et al.
Publicado: (2016)

Effects of 0.5% Timolol Maleate Ophthalmic Solution on Heart Rate and Selected Echocardiographic Indices in Apparently Healthy Cats
por: Gunther‐Harrington, C.T., et al.
Publicado: (2016)

Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review
por: Kardasevic, Mediha, et al.
Publicado: (2021)

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
por: Russ, Heloisa Helena, et al.
Publicado: (2013)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
por: Bell, Nicholas P, et al.
Publicado: (2010)

Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
por: Singh, Aastha, et al.
Publicado: (2020)

Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients
por: Yu, Da-Ae, et al.
Publicado: (2022)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
por: Jagdale, Swati, et al.
Publicado: (2016)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue, Kenji, et al.
Publicado: (2014)

Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
por: Shemesh, Gabi, et al.
Publicado: (2012)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials
por: Qiao, Junbo, et al.
Publicado: (2020)

Bilateral Choroidal Detachment Induced by Unilateral Application of a Fixed Combination of Topical Timolol Maleate and Brinzolamide
por: DONMEZ, Oya, et al.
Publicado: (2016)

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
por: Moisseiev, Elad, et al.
Publicado: (2013)

Topical timolol maleate 0.5% after fractional carbon dioxide laser versus fractional carbon dioxide laser alone in treatment of acne scars: split face comparative study
por: Hawwas, Aya Reda Mohamed, et al.
Publicado: (2023)

Ulcerated Infantile Haemangioma of Buttock Successfully Treated With Topical Timolol
por: Thomas, Jayakar, et al.
Publicado: (2013)

Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study
por: Vestita, Michelangelo, et al.
Publicado: (2017)

Treatment of superficial infantile hemangiomas with timolol: Evaluation of short-term efficacy and safety in infants
por: YU, LINJUN, et al.
Publicado: (2013)

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas
por: Chang, Shih-Jen, et al.
Publicado: (2022)

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
por: Kita, Mizuki, et al.
Publicado: (2021)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
por: Singh, Vinod, et al.
Publicado: (2011)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
por: Radcliffe, Nathan M
Publicado: (2014)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
por: Lee, Anne J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ot2qp78ln4rh80rsn0ang5t7rk